Shares of Carl Zeiss Meditec AG (ETR:AFX) have been given a consensus recommendation of “Hold” by the eight analysts that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month target price among brokers that have covered the stock in the last year is €51.36 ($61.14).

AFX has been the subject of a number of analyst reports. Nord/LB set a €60.00 ($71.43) price objective on Carl Zeiss Meditec and gave the company a “buy” rating in a research note on Tuesday, December 12th. Deutsche Bank set a €40.00 ($47.62) price objective on Carl Zeiss Meditec and gave the company a “neutral” rating in a research note on Friday, December 1st. Berenberg Bank set a €48.00 ($57.14) price objective on Carl Zeiss Meditec and gave the company a “buy” rating in a research note on Friday, December 8th. Independent Research set a €54.00 ($64.29) price objective on Carl Zeiss Meditec and gave the company a “neutral” rating in a research note on Friday, December 8th. Finally, Commerzbank set a €42.00 ($50.00) price objective on Carl Zeiss Meditec and gave the company a “neutral” rating in a research note on Friday, December 8th.

Shares of Carl Zeiss Meditec (ETR AFX) opened at €52.40 ($62.38) on Friday. The firm has a market capitalization of $4,700.00 and a P/E ratio of 33.38. Carl Zeiss Meditec has a 52 week low of €33.62 ($40.02) and a 52 week high of €54.70 ($65.12).

COPYRIGHT VIOLATION NOTICE: This piece was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://www.watchlistnews.com/carl-zeiss-meditec-ag-afx-receives-consensus-rating-of-hold-from-brokerages/1804149.html.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company worldwide. It operates through Ophthalmic Devices and Microsurgery segments. The Ophthalmic Devices segment offers optical biometers, ophthalmic microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.